GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 63 filers reported holding GALECTIN THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $248,617 | +33.3% | 129,488 | 0.0% | 0.07% | +32.7% |
| Q2 2023 | $186,463 | -31.4% | 129,488 | 0.0% | 0.06% | -35.3% |
| Q1 2023 | $271,925 | +85.8% | 129,488 | 0.0% | 0.08% | +73.5% |
| Q4 2022 | $146,321 | -47.0% | 129,488 | -23.6% | 0.05% | -52.4% |
| Q3 2022 | $276,000 | +24.3% | 169,578 | 0.0% | 0.10% | +35.5% |
| Q2 2022 | $222,000 | -18.7% | 169,578 | 0.0% | 0.08% | -6.2% |
| Q1 2022 | $273,000 | -28.2% | 169,578 | -7.6% | 0.08% | -22.1% |
| Q4 2021 | $380,000 | -47.0% | 183,457 | -0.7% | 0.10% | -39.2% |
| Q3 2021 | $717,000 | +21.3% | 184,742 | 0.0% | 0.17% | +25.7% |
| Q2 2021 | $591,000 | +47.4% | 184,742 | 0.0% | 0.14% | +38.8% |
| Q1 2021 | $401,000 | -3.1% | 184,742 | 0.0% | 0.10% | -10.1% |
| Q4 2020 | $414,000 | -16.0% | 184,742 | 0.0% | 0.11% | -25.3% |
| Q3 2020 | $493,000 | -12.7% | 184,742 | 0.0% | 0.15% | -20.7% |
| Q2 2020 | $565,000 | +121.6% | 184,742 | +107.0% | 0.18% | +104.4% |
| Q4 2019 | $255,000 | -22.3% | 89,240 | 0.0% | 0.09% | -15.1% |
| Q3 2019 | $328,000 | -11.4% | 89,240 | 0.0% | 0.11% | -9.4% |
| Q2 2019 | $370,000 | +27.6% | 89,240 | +57.1% | 0.12% | +42.7% |
| Q1 2019 | $290,000 | +46.5% | 56,800 | -1.7% | 0.08% | +9.3% |
| Q4 2018 | $198,000 | -41.8% | 57,800 | +2.3% | 0.08% | -35.3% |
| Q3 2018 | $340,000 | -0.9% | 56,500 | +4.6% | 0.12% | -12.1% |
| Q2 2018 | $343,000 | +35.0% | 54,000 | +0.7% | 0.13% | +32.0% |
| Q1 2018 | $254,000 | +76.4% | 53,600 | +24.4% | 0.10% | +69.5% |
| Q4 2017 | $144,000 | +23.1% | 43,100 | -21.1% | 0.06% | +28.3% |
| Q3 2017 | $117,000 | -15.8% | 54,600 | -3.5% | 0.05% | -16.4% |
| Q2 2017 | $139,000 | +6.9% | 56,600 | 0.0% | 0.06% | +1.9% |
| Q1 2017 | $130,000 | +271.4% | 56,600 | +57.2% | 0.05% | +285.7% |
| Q4 2016 | $35,000 | -22.2% | 36,000 | -8.9% | 0.01% | -30.0% |
| Q3 2016 | $45,000 | -29.7% | 39,500 | -9.2% | 0.02% | -25.9% |
| Q2 2016 | $64,000 | +42.2% | 43,500 | +38.1% | 0.03% | +28.6% |
| Q1 2016 | $45,000 | -13.5% | 31,500 | 0.0% | 0.02% | -12.5% |
| Q4 2015 | $52,000 | -38.1% | 31,500 | -12.5% | 0.02% | -41.5% |
| Q3 2015 | $84,000 | -14.3% | 36,000 | 0.0% | 0.04% | +5.1% |
| Q2 2015 | $98,000 | – | 36,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cutter & CO Brokerage, Inc. | 169,578 | $222,000 | 0.08% |
| Geneos Wealth Management Inc. | 478,067 | $626,000 | 0.03% |
| SHEPHERD KAPLAN KROCHUK, LLC | 12,000 | $16,000 | 0.01% |
| Atria Wealth Solutions, Inc. | 281,700 | $369,000 | 0.01% |
| Vivaldi Capital Management LP | 17,078 | $22,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 1,284,481 | $1,684,000 | 0.00% |
| Ameritas Advisory Services, LLC | 45,302 | $59,000 | 0.00% |
| CENTAURUS FINANCIAL, INC. | 20,947 | $27,000 | 0.00% |
| Summit Trail Advisors, LLC | 23,855 | $31,000 | 0.00% |
| WEDBUSH SECURITIES INC | 27,998 | $37,000 | 0.00% |